1. The 24 h urinary excretions of Porter-Silber (P-S) chromogens, 17-hydroxycorticosteroids (17-OHCS) and free cortisol, and day-night variation of plasma P-S chromogens, were studied in normal and obese women and patients with a confirmed diagnosis of Cushing's syndrome.
and in urine cortisol, cortisone and their tetrahydro-reduced metabolites. Urinary steroids referred to in this paper as 17-hydroxycorticosteroids (17-OHCS) are the C-21 steroids which have a hydroxyl group at C-17 and include cortisol, cortisone and their most important metabolites.
Schultz, Kerlow & Ulstrom (1964) found normal amounts of P-S chromogens in urine and plasma from obese women who had no clinical signs of adrenocortical hyperfunction. However, elevated urinary P-S chromogens have been reported for some obese subjects (Szenas & Pattee, 1959; Migeon, Green & Eckert, 1963; Rosner, Cos, Biglieri, Hane & Forsham, 1963; Schteingart, Gregerman & Conn, 1963; Schachner, Wieland, Maynard, Kruger & Hamwi, 1965; Ernest, 1966; Streeten, Stevenson, Dalakos, Nicholas, Dennick & Fellerman, 1969) and in one investigation (Rosner et al., 1963) raised steroid concentrations were found more frequently in subjects with clinical features suggestive of Cushing's syndrome. In contrast, the plasma P-S chromogens for obese subjects may be normal or slightly below normal values (Schteingart et al., 1963; Streeten et al., 1969) , or well below normal (Rosner et al., 1963) . Schteingart et al. (1963) found that there was considerable overlap in urinary P-S chromogens for obese subjects and those with Cushing's syndrome, whereas the morning plasma concentrations were somewhat higher in the latter group but within the normal range.
On the other hand, the morning concentrations of plasma P-S chromogens may be elevated in patients with Cushing's syndrome (Streeten et al., 1969; Kornel, 1969) . Although a number of subjects in both these studies had normal concentrations, the former workers found that in all their patients with Cushing's syndrome concentrations were elevated from midday onwards. However, other workers (Ekman, Hhkansson, McCarthy, Lehmann & Sjogren, 1961; Ernest, 1966) have found an occasional value within the control range at midnight.
Elevated urinary 17-OHCS have been reported in a significant number of obese subjects (Simkin, 1961; Baird, 1963; McHardy-Young, Harris, Lessof & Lyne, 1967) and in most instances of Cushing's syndrome (Ekman et al., 1961 ; Ernest, 1966) . However, a marked daily variation in urinary 17-OHCS excretion can occur and repeated estimations show that the value may be within the control range on some days (Ernest, 1966) .
Increased cortisol secretion (Schteingart et al., 1963) and production rates (Karl & Raith, 1961; Mlynaryk, Gillies, Murphy & Pattee, 1962; Migeon et al., 1963; Jackson & Mowatt, 1970) have been reported in obesity and Cushing's syndrome. However, in contrast to most subjects with Cushing's syndrome, the unconjugated urinary cortisol for obese subjects falls within the normal range (Rosner et al., 1963; Schteingart et al., 1963; Murphy, 1968; Streeten et al., 1969; Hankin, Theile & Steinbeck, 1972) . These apparently discrepant results have been attributed (Schteingart et al., 1963; Migeon et al., 1963; Rabinowitz, 1970) to increased turnover rates for cortisol in obesity.
Day-night variation of plasma corticosteroids is usually absent in subjects with adrenocortical hyperactivity and normal in most cases of obesity (Schteingart et al., 1963; Ernest, 1966; Espiner, 1966; Streeten et al., 1969) . However, some subjects with Cushing's syndrome may maintain a normal rhythm (Schteingart et al., 1963; Ernest, 1966; Espiner, 1966) and the variation may be absent in some apparently normal subjects and some with obesity (Ekman et al., 1961; McHardy-Young et al., 1967; Jackson & Mowatt, 1970; Hankin et al., 1972) .
In the present study comparisons have been made between unconjugated cortisol and P-S chromogens in urine from normal and obese subjects and patients with Cushing's syndrome.
Urinary 17-OHCS have also been compared. The accuracy of urinary excretion of unconju-gated cortisol and the day-night variation of plasma corticosteroid as means of differentiating between obesity and Cushing's syndrome is also discussed.
SUBJECTS, MATERIALS A N D METHODS

Subjects
The control subjects, for whom details of age, height and weight are given in the hospital. All had a primary diagnosis of obesity and were 20% or more above the accepted limit for Australians of similar height (Standard Height and Weight Tables for Australians, 1957) . The obese and normal subjects were matched for age. Eleven of the subjects with Cushing's syndrome, for whom relevant clinical data are given in Table 1 , underwent bilateral adrenalectomy. The original diagnosis in all these cases was confirmed by the adrenal pathology findings at operation, and the subsequent regression of clinical symptoms, and at post mortem for the remaining subject who died soon after admission to hospital.
Determinations
The methods for urine and plasma collection and storage, and measurement of urinary creatinine and unconjugated cortisol in the urine have been described previously (Hankin et al., 1972) . P-S chromogens. The plasma P-S chromogens were estimated by the method of Peterson, Karrer & Guerra (1957); for urinary P-S chromogens the method of Peterson, Wyngaarden, Guerra, Brodie & Bunim (1955) was followed with minor modifications. Urine (6 ml) was extracted with dichloromethane (25-30 ml) and an aliquot of dichloromethane (5-10 ml) was taken for the colour reaction. Precision for plasma and urine methods was 6 and 13% respectively.
17-Hydroxycorticosteroids. Urinary 17-OHCS were estimated colorimetrically according to the method of Appleby, Gibson, Norymberski & Stubbs (1955) . The precision of the method was 10%.
Dexamethasone suppression test. This was performed on those obese subjects who had Cushingoid features (see below). Patients were given 0.5 mg of dexamethasone every 6 h by mouth for 3 days and 24 h urine collections were made at the same time.
Statistical methods. The differences between mean values in the various groups were examined by Student's t-test. The significances of mean differences within the same subject were assessed by the paired t-test.
Analysis of covariance (Fisher, 1970) was also performed. The analysis has been deposited as Table 7413 with the Librarian, The Royal Society of Medicine (see above).
R E S U L T S
Clinical data
The clinical data for the patients with Cushing's syndrome are shown in Table 1 . Four of the obese subjects had a frankly Cushingoid appearance with florid complexions, nuchal fat pads, truncal fat deposition, thin limbs, muscle weakness, discoloured striae and hypertension.
Body weight
All the subjects with Cushing's syndrome were above the mean weight for their height but one-third were within the accepted upper limit of normal and only one-third could be considered to be grossly obese (Table 1 ). The mean weights are summarized in Table 2 . The mean weight of the obese subjects was significantly higher (P<O*OOl) than that for normal subjects, and those with Cushing's syndrome. The mean weight of the subjects with Cushing's syndrome was significantly higher (P<O,OOI) than that of the normal woman.
Creatinine excretiori
Urinary creatinine was determined to assess the adequacy of collections. The normal range was taken as 0.8-2.2 g/24 h. All the creatinine values fell within this range with the exception of one obese subject (C.M.) who consistently excreted amounts of approximately 2.5 g/24 h.
P-S chromogens in plasma
Individual values at 09.00 and 21 .OO hours are shown in Fig. I . Two normal and two obese women failed to show a significant day-night variation. Only four of the patients with Cushing's syndrome showed a significant day-night variation.
The mean values ( +SD) at 09.00 hours for normal (17f8 pg/lOO ml; range 8-34) and obese women (21 _+ 13 pg/lOO ml; range 6-49) were similar. The mean values at 21.00 hours for normal (8+6 pg/lOO ml; range 0-18) and obese (9+9 pg/100 ml; range 1-23) women were also similar.
The mean concentrations at 09.00 hours were significantly higher than those at 21 .OO hours for the normal (P<0-025) and obese (P<0.05) groups. The mean concentration at 09.00 hours for patients with Cushing's syndrome (40 &22 ,ug/lOO ml; range 14-79) was significantly higher than those for both the normal (P.eO.05) and the obese (P<0.05) groups. The mean value at 21.00 hours for these patients (33f25 pg/lOO ml; range 15-108) was significantly higher than those for both the normal (P<0.025) and obese (P<0.025) women. There was no significant difference between the mean values at 09.00 and 21.00 hours for the patients with Cushing's syndrome.
-
P-S chromogens in urine
Individual and mean values for the excretion of P-S chromogens for the three groups of women are shown in Fig. 2 and Table 3 respectively. The individual excretions expressed either in absolute amounts or as mg/kg body weight were within the normal range for the obese subjects. Although all the absolute excretions were elevated, 50% of the values for the women with Cushing's syndrome fell within the normal range when they were expressed as mg/kg body weight.
The mean absolute value for the normal group (4.4 k 2.2 mg/24 h; range 1.6-9.7) was similar to that of the obese group (6.0f 1.4 mg/24 h; range 4.2-7.7). However, the mean value for the Cushing's patients (17.2f7.8 mg/24 h; range 10.0-31.4) was significantly higher than those for both the normal (P<O-OOI) and obese (P<O.OOl) women. When the mean absolute values were expressed as mg/kg body weight no significant difference was found between the values for the normal (0.08+0.04 mg/kg; range 0.03-0.18) and obese (0.05+0.02 mg/kg; range 0-02-0*08) women but the value for the patients with Cushing's syndrome (0.25+0*11 mg/kg; range 0.13441) was significantly higher than those for both the normal (Pt0.001) and obese (P < 0401) women. 
17-OHCS in urine
Individual values in absolute amounts and expressed as mg/kg body weight are shown in Fig. 2 and the means and standard deviations for the excretion of 17-OHCS in urine for the three groups are shown in Table 3 . The mean excretions for the normal (11.7f2.8 mg/24 h; range 3.9-16.4) and the obese (12.014.4 mg/24 h ; range 5-2-23.7) groups were not significantly different.
12.3 mg/24 h; range 19-7-62-4) was significantly higher than those of the normal (P< 0.001) and the obese(P< 0.001) groups. Two of the obese women and all the subjects with Cushing's syndrome had values which exceeded the upper limit of the normal range. However, when the concentrations were expressed as mg/kg body weight (Fig. 2) the mean for the obese group (0.1 1 f0-05 mg/kg; range 0.04-0.24) was significantly lower (P<O.OOl) than that for the normal women (0.21 f 0.06 mg/kg; range 0-07-0.30). The mean concentration for the subjects with Cushing's syndrome (0.45 f 0.16 mg/kg; range 0.26-0.82) was significantly higher then the mean concentrations for the normal and obese subjects (P<O.OOl and P<O.OOl respectively).
The mean excretion for the group with Cushing's syndrome (31.3
Free cortisol excretion
The individual and mean values for the excretion of free cortisol in urine for the three groups are shown in Fig. 3 and Table 3 . None of the values of the obese subjects exceeded the upper limit of the normal but, with two exceptions, the patients with Cushing's syndrome had elevated free cortisol excretions.
The mean excretion for the obese women (26+ 16 ,ug/24 h; range 4-64) was similar to that of the normal women (31 zL-18 ,ug/24 h; range 12-75). However, the mean for the group with
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Cushing's syndrome (2925 264 1.18124 h; range 44-751) was significantly higher than that of the normal group (P<O-OOI) and that of the obese group (P<O-OOI).
When the excretions were expressed as pglkg body weight there was no clear-cut demarcation between the individual values but the values for the obese subjects tended to be outside the lower limit of normal and the opposite trend was observed for those subjects with Cushing's syndrome. The mean value for the normal group (0.5f0.3 ,ug/kg; range 0.3-1-1) was significantly higher (P< 0.005) than that for the obese subjects (0-3 k 0.2 pg/kg; range 0.03-0.8) and significantly lower (P<O.OOI) than that of the group with Cushing's syndrome (4.3 k 3.8 pg/kg; range 0.6-1 1.1). The mean value for the obese group was significantly lower (P<O.OOI) than that of the group with Cushing's syndrome. 
Dexamethasone suppression tests
In the four obese subjects who had a Cushingoid appearance urinary excretion of 17-OHCS was suppressed to less than 3.4 mg/24 h after dexamethasone. In contrast, in none of the patients with Cushing's syndrome could the excretion of 17-OHCS be suppressed to below 8.5 mg/24 h. In addition, the latter patients showed normal diurnal variation of plasma cortisol or P-S chromogen, with normal morning concentrations, and urinary free cortisol excretion was within the normal range. For these reasons surgery was not undertaken. Subsequent follow-up over a period of 4 years has confirmed that none of the obese subjects had Cushing's syndrome.
Correlation between measurements
No correlation was found between the different urinary values investigated in any of the three groups of subjects or between the urinary and plasma values for the subjects with Cushing's syndrome. Because of limited data available urinary and blood values were not compared for the normal and obese subjects.
DISCUSSION
Grossly obese subjects are frequently referred to endocrine clinics for the investigation of their adrenocortical function or assessment of corticosteroid values. The results of the present study and that of Ernest & Ekman (1972) indicate that obesity is not necessarily a feature of Cushing's syndrome. However, some obese subjects exhibit other features suggestive of adrenocortical hyperactivity. Thus there is a need to select a procedure that will confirm or deny the possibility conclusively. Elevated concentrations of plasma corticosteroids, particularly at night, and absence of day-night variation are often considered to be indicative of excessive adrenocortical hormone production. Although the individual values of plasma P-S chromogens tended to be higher in the patients with Cushing's syndrome than in the normal and the obese subjects there was some overlap in all three groups both at 09.00 and 21 .OO hours. Some workers have reported relatively lower mean P-S chromogens in plasma for the obese than the lean (Szenas & Pattee, 1959) ; others have found that they are within the normal range (Migeon et al., 1963; Schultz et al., 1964) . The observation that some subjects with Cushing's syndrome may have values within the normal range confirms the studies of several other workers (Ekman et al., 1961 ; Kornel, 1969) . Similarly the finding that a few subjects with Cushing's syndrome may maintain day-night variation of plasma corticosteroids, and that it may be absent in some apparently normal subjects and in cases of obesity, has been noted (Ekman et al., 1961 Although the excretion is usually elevated in Cushing's syndrome P-S chromogens may be in the normal range (Schteingart et al., 1963; Ernest, 1966) . In the present study the urinary P-S chromogens were within the normal range for the obese subjects but raised in all the patients with Cushing's syndrome. However, the highest value for the normal subjects (9.7 mg/24 h) was virtually identical with the lowest value for the subjects with Cushing's syndrome (10 mg/24 h). A similar pattern was found when the daily steroid excretions were expressed as mg/kg body weight.
The urinary 17-OHCS expressed in absolute amounts were elevated in some of the women with simple obesity and Cushing's syndrome. Similar patterns have been reported for the obese (Baird, 1963) and subjects with Cushing's syndrome (Ernest, 1966) . When the values were expressed as mg/kg body weight none of the obese subjects had elevated amounts and the occasional value for the Cushingoid patients fell within the normal range.
Urinary free cortisol is considered to be a sensitive gauge of cortisol production and the amount of this steroid is similar in normal and obese women (see Hankin et al., 1972, for further discussion). Elevated excretions, which are relatively consistent, have been reported for patients with Cushing's syndrome of varying aetiology (Rosner et al., 1963; Murphy, 1968) . However, the results of the present study indicated that this is not necessarily so. Several subjects on whom only single estimatioos were made had free Cortisol excretions which were well within the normal range and another had values that were normal on one occasion and markedly elevated on several others. Similarly, when the cortisol excretions were expressed as pg/kg body weight, the values for several of the patients with Cushing's syndrome overlapped those of both the obese and normal groups.
None of the measurements so far discussed clearly delineates between simple obesity and Cushing's syndrome. However, dexamethasone suppression tests were normal for the subjects with simple obesity and possible adrenocortical hyperactivity and abnormal for all subjects with Cushing's syndrome. Similar findings have been reported previously (Schteingart et al., 1963) .
It is concluded that adrenocortical hyperfunction is not a significant feature of simple obesity. Should a clinical doubt arise adrenal suppression with dexamethasone appears the simplest means of excluding hyperfunction.
